Objective To review the data presented in the 2021 WHO global TB report and discuss the
current constraints in the global response. Introduction and methods The WHO global TB …

Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses to
previously acquired Mycobacterium tuberculosis infection without clinical evidence of active …

Background: The American Thoracic Society, US Centers for Disease Control and
Prevention, European Respiratory Society, and Infectious Diseases Society of America …

Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …

Background A 9-month regimen of isoniazid can prevent active tuberculosis in persons with
latent tuberculosis infection. However, the regimen has been associated with poor …

Background WHO estimates that a third of the world's population has latent tuberculosis
infection and that less than 5% of those infected are diagnosed and treated to prevent …

The WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment
provides a comprehensive set of recommendations for programmatic management of …

Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-
resistant tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …

ABSTRACT Objectives The World Health Organization estimated that a quarter of the global
population is infected by Mycobacterium tuberculosis (Mtb). A better control of tuberculosis …

Latent tuberculosis infection was the term traditionally used to indicate tuberculosis (TB)
infection. This term was used to define “a state of persistent immune response to stimulation …